BioXcel Therapeutics Inc   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Branford CT United States (2017)

Organization Overview

First Clinical Trial
2019
NCT03910660
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

BioXcel Therapeutics Inc